Human Genome Sciences prices $430M loan deal while Benlysta ramps
This article was originally published in Scrip
Executive Summary
Human Genome Sciences said it has priced a $430 million offering involving the sale of 3% senior convertible notes due 15 November 2015, which was upsized from the previously announced $400 million offering.